Related Experiment Videos
Recent advances in the molecular biology of hepatitis C virus
1Department of Chemistry, University of California, Berkeley, CA 94720, USA. srbchem@pacbell.net
Insights
Hepatitis C virus (HCV) research advances with new cell culture and animal models, aiding antiviral development. Structural biology reveals key enzyme structures, offering insights into viral replication mechanisms.
Area of Science:
- Virology
- Molecular Biology
- Structural Biology
- Hepatology
Background:
- Hepatitis C virus (HCV) causes chronic liver infection in over 170 million people globally.
- HCV's 9.6 kb genome encodes a polyprotein processed into viral proteins, with NS4b and NS5a functions remaining elusive.
- Antiviral development for HCV is hindered by limitations in cell culture and animal infection models.
Purpose of the Study:
- To review recent advancements in Hepatitis C virus molecular virology and structural biology.
- To highlight progress in developing robust models for HCV research.
- To discuss the implications of these advancements for understanding HCV replication and developing antivirals.
Main Methods:
- Development of infectious molecular clones for chimpanzee studies.
- Establishment of a subgenomic replicon system in Huh7 cells.
- Creation of a transgenic mouse model for HCV infection.
- Determination of high-resolution 3D structures of key viral enzymes (NS3 protease, NS3 helicase, NS5b RNA-dependent RNA polymerase) using techniques like X-ray crystallography.
- Investigation of host factors involved in HCV replication using various biochemical and molecular techniques.
Main Results:
- Progress in molecular virology includes infectious clones, replicon systems, and transgenic mouse models.
- Structural biology efforts have yielded high-resolution 3D structures of critical HCV enzymes, some complexed with substrates, co-factors (NS4a), or inhibitors.
- Early investigations into host factors essential for HCV replication have commenced.
Conclusions:
- Recent breakthroughs in molecular and structural virology have significantly advanced the understanding of Hepatitis C virus.
- The development of improved research models and structural data on viral enzymes provides a strong foundation for future antiviral drug discovery.
- Further research into host-virus interactions is crucial for comprehensive HCV control strategies.
Abstract:
The Hepatitis C virus is a positive-stranded RNA virus which is the causal agent for a chronic liver infection afflicting more than 170,000,000 people world-wide. The HCV genome is approximately 9.6 kb in length and the proteome encoded is a polyprotein of a little more than 3000 amino acid residues. This polyprotein is processed by a combination of host and viral proteases into structural and non-structural proteins. The functions of most of these proteins have been established by analogy to other viruses and by sequence homology to known proteins, as well as subsequent biochemical analysis. Two of the non-structural proteins, NS4b and NS5a, are still of unknown function. The development of antivirals for this infectious agent has been hampered by the lack of robust and economical cell culture and animal infection systems. Recent progress in the molecular virology of HCV has come about due to the definition of molecular clones, which are infectious in the chimpanzee, the development of a subgenomic replicon system in Huh7 cells, and the description of a transgenic mouse model for HCV infection. Recent progress in the structural biology of the virus has led to the determination of high resolution three-dimensional structures of a number of the key virally encoded enzymes, including the NS3 protease, NS3 helicase, and NS5b RNA-dependent RNA polymerase. In some cases these structures have been determined in complex with substrates, co-factors (NS4a), and inhibitors. Finally, a variety of techniques have been used to define host factors, which may be required for HCV replication, although this work is just beginning.